Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome.
about
Exploring BAFF: its expression, receptors and contribution to the immunopathogenesis of Sjögren's syndromeB-cell survival factors in autoimmune rheumatic disordersAdvances in the Aetiophatogenesis of Sjögren's Syndrome: a Literature ReviewReviewing primary Sjögren's syndrome: beyond the dryness - From pathophysiology to diagnosis and treatmentType I interferon receptor deficiency prevents murine Sjogren's syndromeSalivary gland hypofunction induced by activation of innate immunity is dependent on type I interferon signaling.Activation of innate immunity accelerates sialoadenitis in a mouse model for Sjögren's syndrome-like disease.The Association Between Sjögren Syndrome and Adverse Postoperative Outcomes: A Historical Cohort Study Using Administrative Health DataNetwork-assisted analysis of primary Sjögren's syndrome GWAS data in Han ChineseHigh-dose methylprednisolone pulse therapy upregulated FcγRIIb expression on B cells in primary Sjögren's syndrome patients with thrombocytopenia.Sjogren's syndrome: Review of the aetiology, Pathophysiology & Potential therapeutic interventions.Candidate chromosome 1 disease susceptibility genes for Sjogren's syndrome xerostomia are narrowed by novel NOD.B10 congenic mice.Identification of a Sjögren's syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons.Rituximab in primary Sjögren's syndrome: a ten-year journey.Identification of regulatory factors for mesenchymal stem cell-derived salivary epithelial cells in a co-culture system.Innate immune signaling induces interleukin-7 production from salivary gland cells and accelerates the development of primary Sjögren's syndrome in a mouse modelDysfunction of lacrimal and salivary glands in Sjögren's syndrome: nonimmunologic injury in preinflammatory phase and mouse model.Matriptase deletion initiates a Sjögren's syndrome-like disease in mice.Emerging roles for the Ro 60-kDa autoantigen in noncoding RNA metabolism.Contribution of IL-13 to early exocrinopathy in Id3-/- mice.Transcriptome analysis of the interferon-signature defining the autoimmune process of Sjögren's syndromeExpression of IL-17, IL-23 and their receptors in minor salivary glands of patients with primary Sjögren's syndromeTelocytes in minor salivary glands of primary Sjögren's syndrome: association with the extent of inflammation and ectopic lymphoid neogenesis.Frankincense and myrrh suppress inflammation via regulation of the metabolic profiling and the MAPK signaling pathwayLocal delivery of AAV2-CTLA4IgG decreases sialadenitis and improves gland function in the C57BL/6.NOD-Aec1Aec2 mouse model of Sjögren's syndrome.Interleukin-6 inhibits apoptosis of exocrine gland tissues under inflammatory conditionsRisk of asthma in patients with primary Sjögren's syndrome: a retrospective cohort studyUse of a novel high-resolution magnetic resonance neurography protocol to detect abnormal dorsal root Ganglia in Sjögren patients with neuropathic pain: case series of 10 patients and review of the literature.Innate Immune Signaling Induces IL-7 Production, Early Inflammatory Responses, and Sjögren's-Like Dacryoadenitis in C57BL/6 Mice.T Cell-Associated Cytokines in the Pathogenesis of Sjögren's SyndromeInterleukin-7 enhances the Th1 response to promote the development of Sjögren's syndrome-like autoimmune exocrinopathy in miceRisk of Chronic Obstructive Pulmonary Disease in Female Adults With Primary Sjögren Syndrome: A Nationwide Population-Based Cohort Study.Targeting the Ca(2+) Sensor STIM1 by Exosomal Transfer of Ebv-miR-BART13-3p is Associated with Sjögren's SyndromeEndogenous programmed death ligand-1 restrains the development and onset of Sjӧgren's syndrome in non-obese diabetic mice.Expression of resolvin D1 biosynthetic pathways in salivary epitheliumCorrelation between Tear Osmolarity and Other Ocular Surface Parameters in Primary Sjögren's Syndrome.Smad4 in T cells plays a protective role in the development of autoimmune Sjögren's syndrome in the nonobese diabetic mouse.Pathogenic role of endogenous TNF-α in the development of Sjögren's-like sialadenitis and secretory dysfunction in non-obese diabetic mice.The Core Pattern Analysis on Chinese Herbal Medicine for Sjögren's syndrome: A Nationwide Population-Based StudyBiological therapies in primary Sjögren's syndrome.
P2860
Q26770648-850997C9-88EC-4844-9EB6-1D589BB8207AQ26796484-879DB0B4-285D-4F3C-A390-271366AA2DBEQ26824039-82871FBB-37C9-465C-BEB9-97B3E1DA0783Q30234992-CB0B3278-9C5A-4BC4-B8C1-D6079015864EQ30413385-E7EF209E-EF6D-4489-AB60-0B1488014B0FQ30415532-9705CA33-C677-409D-840C-74296A3682F9Q30424360-1123765D-39FF-427A-AA27-AAC6733D7A19Q30989911-41EF57ED-BE50-4CD6-A8A4-A8E5B3EEB77CQ31033001-13F2C93A-3AE0-4010-8E13-F93CD9BD9A44Q33409534-05EBA188-ECDC-4877-8825-0719077919F8Q33619691-594C46DD-4FDE-4CC6-BFC7-2C33FD1A3B64Q33758184-87A700D7-7A60-40FB-9CD1-CFBB8C4422FFQ33884499-08B0DC83-5623-4716-95C1-AF632ADEB713Q34432465-AFE2AE7F-65E5-4C91-A923-3B1AF0B70BCEQ34525030-7E44BBA7-03AD-47B1-991B-C4DC9B7751FEQ35023259-82F75B97-415C-47B3-85EE-16C693EDEA99Q35031736-B4E2B80F-D4B0-4E39-8D3D-51470034F6D2Q35097182-81324243-7B6E-4127-B66E-82159D049FB9Q35158086-4DD907F9-DDAE-4DE1-972A-9591853A4F1DQ35488650-61BB114A-324D-49F3-86DB-02BE61299234Q35535151-C091FCC8-F0D8-48EC-9D35-70F5A8AB6B5BQ35676007-C2926EFB-35BF-47A3-828D-D249154ED644Q35879544-EEA2E05C-6254-44AB-972C-7D819051E64FQ36017886-B3A229F7-6E91-41CE-B0CA-1C225615C75CQ36085054-79D33449-4B91-43B0-B4EF-3E3AC0F640BFQ36161896-8BBCE0AF-4E14-4551-9F5F-1DE705A5FCD3Q36194492-042ABED8-22FD-46D4-AFF5-94F0C3D1A6E0Q36247817-2E50C157-3C06-4A6C-ACFE-EAA735833409Q36380242-A06A791F-CAE8-4E3A-80B9-20224AEC89C5Q36957148-03FCEAE2-BFC8-4675-88B7-41E128C01824Q37060371-DC225CC7-8345-4139-9C19-D8DE2C17D495Q37207194-8EFDBF22-FDE7-4BC9-B18B-AC6EA6207B14Q37221504-569DE862-2234-4118-BA12-22B4DD78CF34Q37501812-3F643BF4-0B42-4E8A-8C60-D9F4D6DBF98BQ37594573-A6873C48-7C66-4C34-946E-099F047035FAQ37667670-522AFA71-FD21-4F87-8A0B-1C68DA436D0CQ37696996-FD073003-19A5-48C2-8008-641B171DCA1DQ37733323-15FECC82-F8A9-430F-83C3-9D1B90DA5AA3Q37744586-2B7BD4CA-8530-447F-BDDC-814A4181769BQ37860347-29015AF9-A5B4-4A47-B65A-70FD72DBAC2C
P2860
Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome.
@en
Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome.
@nl
type
label
Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome.
@en
Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome.
@nl
prefLabel
Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome.
@en
Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome.
@nl
P356
P1476
Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome.
@en
P2093
Athanasios G Tzioufas
Michael Voulgarelis
P2888
P304
P356
10.1038/NRRHEUM.2010.118
P407
P577
2010-08-03T00:00:00Z